14 unknown. 14 Phase 2, 6 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Unknown 14 |
| Phase 3 | 6 | Unknown 6 |
| Phase 1 | 3 | Unknown 3 |
Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia TP-122A - Pneumonia, Ventilator-Associated | Phase 1 / Phase 2 | Unknown | Technophage, SA | 15 | 2024-09-01 | 2024-04-17 |
| "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. Baricitinib 4 MG - Hospital-acquired Pneumonia | Phase 2 / Phase 3 | Unknown | Nantes University Hospital | 450 | 2023-07-01 | 2023-06-22 |
| Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease Bromelains, Acetylcysteine - COVID-19 Pneumonia, COVID-19 | Phase 1 / Phase 2 | Unknown | Mucpharm Pty Ltd | 30 | 2022-05-01 | 2022-02-28 |
| Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia UC-MSCs - Pneumonia, Viral, Pneumonia, Ventilator-Associated | Phase 2 | Unknown | ZhiYong Peng | 16 | 2020-02-06 | 2020-07-01 |
| Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections Antimicrobial Surface - Healthcare Associated Infection | Phase 2 | Unknown | Aionx, Inc. | 10000 | 2017-07-01 | 2017-06-16 |
| The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia Ulinaststin for injection, placebo - Ventilator-associated Bacterial Pneumonia, Mechanical Ventilation Complication | Phase 2 / Phase 3 | Unknown | Shanghai Minhang Central Hospital | 60 | 2014-01-01 | 2013-05-30 |
| Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults Colistimethate sodium - Hospital-acquired Pneumonia | Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 60 | 2013-10-01 | 2013-09-12 |
| Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections Neomycin Colistin Nystatin Vancomycin - Bacteremia Associated With Intravascular Line, Ventilator Associated Pneumonia | Phase 2 / Phase 3 | Unknown | Rambam Health Care Campus | 2400 | 2013-06-01 | 2013-02-26 |
| Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia C Group, E Group - Nosocomial Pneumonia | Phase 2 / Phase 3 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 50 | 2012-03-01 | 2016-02-17 |
| Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants Talactoferrin, Placebo - Nosocomial Infections | Phase 1 / Phase 2 | Unknown | Agennix | 120 | 2009-06-01 | 2012-03-15 |
| Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation Nebulized amikacin, Intravenous amikacin, Placebo nebulization - Ventilator Associated Pneumonia | Phase 2 / Phase 3 | Unknown | Association Pour La Promotion A Tours De La Reanimation Medicale | 24 | 2009-01-01 | 2009-03-16 |
| Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone Hypochlorous acid, Iodopovidone - Surgical Site Infection | Phase 2 | Unknown | Universidad Tecnológica de Pereira | 432 | 2008-07-01 | 2008-10-21 |
| Removal of Endotracheal Tube Secretions Comprehensively Until Extubation CAM (Complete Airway Management) Catheters - Mechanical Ventilation, Pneumonia | Phase 2 | Unknown | O. M. Neotech, Inc. | 30 | 2008-04-01 | 2008-05-29 |
| Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia Toothbrushing - Ventilator-Associated Pneumonia, Nosocomial Pneumonia | Phase 2 / Phase 3 | Unknown | Hospital Universitari Joan XXIII de Tarragona. | 400 | 2005-05-01 | 2009-02-12 |
Pneumonia, Ventilator-Associated (8) · Healthcare-Associated Pneumonia (4) · Pneumonia (3) · COVID-19 (2) · Bacteremia (1) · Bites and Stings (1) · Pneumonia, Viral (1) · Surgical Wound Infection (1)
Disease Attributes (14) · Iatrogenic Disease (14) · Infections (14) · Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Lung Diseases (11) · Respiratory Tract Diseases (11) · Respiratory Tract Infections (11) · Pneumonia (8) · Healthcare-Associated Pneumonia (7) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Nidovirales Infections (2) · RNA Virus Infections (2)
Acetylcysteine (1) · Bromelains (1) · Catheters (1) · Colistin (1) · Complementary Therapies (1) · Hypochlorous Acid (1) · Injections (1) · Neomycin (1) · Povidone-Iodine (1) · Toothbrushing (1) · Vancomycin (1) · baricitinib (1) · colistinmethanesulfonic acid (1) · talactoferrin alfa (1)
Agennix (1) · Aionx, Inc. (1) · Association Pour La Promotion A Tours De La Reanimation Medicale (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Hospital Universitari Joan XXIII de Tarragona. (1) · Mucpharm Pty Ltd (1) · Nantes University Hospital (1) · O. M. Neotech, Inc. (1) · Rambam Health Care Campus (1) · Shanghai Minhang Central Hospital (1) · Technophage, SA (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Universidad Tecnológica de Pereira (1) · ZhiYong Peng (1)
China (4) · France (3) · Spain (2) · United States (2) · Belgium (1) · Colombia (1) · Israel (1) · Netherlands (1)
Frank MP van Haren, MD, PhD (1) · Jordi Rello, MD, PhD (1) · Jose A Stoute, M.D. (1) · Juliana Buitrago, MD.,MSc (1) · Margarida Barreto, Msc (1) · Mical Paul, Prof. (1) · Orlando V. Morejon, MD (1) · Wang Donghao, Chief (1) · XingHuan Wang, professor (1) · Yaron P Bar-Lavie, M.D. (1)
PMID 19482956, PMID 27234409, PMID 27260839
R44HD057744 (1)